Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) EBT: 2020-2024

Historic EBT for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to -$195.9 million.

  • Prime Medicine's EBT fell 0.60% to -$52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.6 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of -$195.9 million for FY2024, which is 1.28% up from last year.
  • As of FY2024, Prime Medicine's EBT stood at -$195.9 million, which was up 1.28% from -$198.4 million recorded in FY2023.
  • Over the past 5 years, Prime Medicine's EBT peaked at -$1.5 million during FY2020, and registered a low of -$198.4 million during FY2023.
  • In the last 3 years, Prime Medicine's EBT had a median value of -$195.9 million in 2024 and averaged -$172.4 million.
  • As far as peak fluctuations go, Prime Medicine's EBT plummeted by 10,648.74% in 2021, and later grew by 25.98% in 2022.
  • Prime Medicine's EBT (Yearly) stood at -$1.5 million in 2020, then plummeted by 10,648.74% to -$165.9 million in 2021, then increased by 25.98% to -$122.8 million in 2022, then plummeted by 61.61% to -$198.4 million in 2023, then grew by 1.28% to -$195.9 million in 2024.